Research and Markets: Parasitic Partnering 2007-2013

Research and Markets: Parasitic Partnering 2007-2013

<0> Research and MarketsLaura Wood, Senior Manager.U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Sector: </0>

() has announced the addition of the report to their offering.

The Parasitic Partnering 2007-2013 provides understanding and access to the parasitic partnering deals and agreements entered into by the worlds leading healthcare companies.

This data driven report includes:

In Parasitic Partnering 2007-2013, the available deals are listed by:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in parasitic partnering

2.1. Introduction

2.2. Parasitic partnering over the years

2.3. Bigpharma parasitic dealmaking activity

2.4. Parasitic partnering by deal type

2.5. Parasitic partnering industry sector

2.6. Parasitic partnering by stage of development

2.7. Parasitic partnering by technology type

2.8. Disclosed financial deal terms for parasitic partnering

2.8.1 Parasitic headline values

2.8.2 Parasitic upfront payments

2.8.3 Parasitic milestone payments

2.8.4 Parasitic royalty rates

Chapter 3 - Leading parasitic deals

3.1. Introduction

3.2. Top parasitic deals by value

3.3. Top parasitic deals involving bigpharma

Chapter 4 - Dealmaking directory

4.1. Introduction

4.2. Company A-Z

4.3. By deal type

4.4. By industry sector

4.5. By stage of development

Chapter 5 - Partnering resource center

5.1. Online partnering

5.2. Partnering events

5.3. Further reading on dealmaking


For more information visit

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.